Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02346357Unknown
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Benaroya Research Institute. Primary endpoint: Immediate pain score upon arrival to phase 1 PACU. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02346357.